Nautilus Biotechnology, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $305.6M
Liabilities Breakdown FY2023
Total Liabilities: $40.2M
Asset Breakdown
Total Assets: $305.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $19.4M | 6.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $4.3M | 1.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $281.9M | 92.3% |
Liabilities Breakdown
Total Liabilities: $40.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.6M | 4.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $38.6M | 95.9% |